Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - GENVEC INC | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 12, 2014
GenVec, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware
(state or other jurisdiction of
incorporation) |
000-24469
(Commission
File Number)
|
23-2705690
(I.R.S. Employer
Identification No.)
|
|
910 Clopper Road
Suite 220N
Gaithersburg, Maryland
|
20878
(Zip Code) |
|
(Address of principal executive offices)
|
Registrant’s telephone number, including area code: (240) 632-0740
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
INFORMATION TO BE INCLUDED IN THE REPORT
Section 2 – Financial Information
Item 2.02 Results of Operations and Financial Condition.
On November 12, 2014, GenVec, Inc. (“GenVec”) issued a press release announcing its financial results for the quarter ended September 30, 2014.
A copy of GenVec’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | ||
|
99.1
|
GenVec, Inc. press release dated November 12, 2014, announcing financial results for the quarter ended September 30, 2014.
|
||
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GENVEC, INC. | |||
| By: | /s/ Douglas J. Swirsky | ||
| Douglas J. Swirsky | |||
| President, Chief Executive Officer and Chief | |||
| Financial Officer | |||
Dated: November 12, 2014
| 3 |
EXHIBIT INDEX
| Exhibit No. | Description | ||
|
99.1
|
GenVec, Inc. press release dated November 12, 2014, announcing financial results for the quarter ended September 30, 2014.
|
||
| 4 |